LRP5, a WNT signalling pathway receptor, and platelet activation

Area of Science:

• Hematology
• Molecular Biology
• Cardiovascular Research

Background:

• Platelets are crucial for hemostasis, thrombosis, and inflammation, with functions regulated by receptor signaling pathways.
• The Wnt signaling cascade member, LRP5, is investigated for its role in platelet function.

Purpose of the Study:

• To investigate the role of LRP5 in platelet function and hemostasis.
• To determine if LRP5 is a potential therapeutic target for modulating platelet activity.

Main Methods:

• Human and mouse platelets (wild-type and Lrp5-deficient) were stimulated with ADP, collagen, and inhibitors.
• Platelet aggregation, flow-dependent deposition, and in vivo thrombosis models were utilized.
• Signaling pathways, including P2Y12, and granule release were assessed.

Main Results:

• Lrp5-deficient mice exhibited significantly reduced platelet aggregation and deposition.
• In vivo thrombosis was prolonged in Lrp5-deficient mice, with impaired P2Y12 signaling and granule release.
• LRP5 inhibition in human platelets reduced aggregation and deposition, without affecting coagulation or inducing bleeding.

Conclusions:

• LRP5 is critical for platelet adhesion and thrombus formation.
• Genetic deletion or inhibition of LRP5 impairs platelet aggregation and thrombosis in preclinical models.
• LRP5 represents a novel therapeutic target for modulating platelet reactivity and thrombosis.